Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer.

Joosse SA, Beyer B, Gasch C, Nastały P, Kuske A, Isbarn H, Horst LJ, Hille C, Gorges TM, Cayrefourcq L, Alix-Panabières C, Tennstedt P, Riethdorf S, Schlomm T, Pantel K.

Clin Chem. 2019 Oct 10. pii: clinchem.2019.310912. doi: 10.1373/clinchem.2019.310912. [Epub ahead of print]

PMID:
31601564
2.

The Different Facets of Liquid Biopsy: A Kaleidoscopic View.

Eslami-S Z, Cortés-Hernández LE, Cayrefourcq L, Alix-Panabières C.

Cold Spring Harb Perspect Med. 2019 Sep 23. pii: a037333. doi: 10.1101/cshperspect.a037333. [Epub ahead of print]

PMID:
31548226
3.

Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer.

Hille C, Gorges TM, Riethdorf S, Mazel M, Steuber T, Amsberg GV, König F, Peine S, Alix-Panabières C, Pantel K.

Cells. 2019 Sep 11;8(9). pii: E1067. doi: 10.3390/cells8091067.

4.

Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.

Garrel R, Mazel M, Perriard F, Vinches M, Cayrefourcq L, Guigay J, Digue L, Aubry K, Alfonsi M, Delord JP, Lallemant B, Even C, Daurès JP, Landais P, Cupissol D, Alix-Panabières C.

Clin Chem. 2019 Oct;65(10):1267-1275. doi: 10.1373/clinchem.2019.305904. Epub 2019 Aug 6.

PMID:
31387885
5.

Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.

Cortés-Hernández LE, Eslami-S Z, Alix-Panabières C.

Mol Aspects Med. 2019 Aug 21. pii: S0098-2997(19)30051-2. doi: 10.1016/j.mam.2019.07.008. [Epub ahead of print] Review.

PMID:
31377345
6.

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment.

Heeke S, Mograbi B, Alix-Panabières C, Hofman P.

Cells. 2019 Jul 13;8(7). pii: E714. doi: 10.3390/cells8070714. Review.

7.

S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells.

Cayrefourcq L, De Roeck A, Garcia C, Stoebner PE, Fichel F, Garima F, Perriard F, Daures JP, Meunier L, Alix-Panabières C.

Cells. 2019 Jul 20;8(7). pii: E755. doi: 10.3390/cells8070755.

8.

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma.

Buscail E, Maulat C, Muscari F, Chiche L, Cordelier P, Dabernat S, Alix-Panabières C, Buscail L.

Cancers (Basel). 2019 Jun 19;11(6). pii: E852. doi: 10.3390/cancers11060852. Review.

9.

Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?

Hofman P, Heeke S, Alix-Panabières C, Pantel K.

Ann Oncol. 2019 Sep 1;30(9):1448-1459. doi: 10.1093/annonc/mdz196.

PMID:
31228184
10.

Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells.

Buscail E, Chiche L, Laurent C, Vendrely V, Denost Q, Denis J, Thumerel M, Lacorte JM, Bedel A, Moreau-Gaudry F, Dabernat S, Alix-Panabières C.

Mol Oncol. 2019 Sep;13(9):1811-1826. doi: 10.1002/1878-0261.12534. Epub 2019 Jul 25. Review.

11.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Budna-Tukan J, Świerczewska M, Mazel M, Cieślikowski WA, Ida A, Jankowiak A, Antczak A, Nowicki M, Pantel K, Azria D, Zabel M, Alix-Panabières C.

Cancers (Basel). 2019 Jun 10;11(6). pii: E802. doi: 10.3390/cancers11060802.

12.

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.

Le Louedec F, Alix-Panabières C, Lafont T, Allal BC, Garrel R, Digue L, Guigay J, Cupissol D, Delord JP, Lallemant B, Alfonsi M, Aubry K, Mazel M, Becher F, Perriard F, Chatelut E, Thomas F.

Br J Clin Pharmacol. 2019 Jun;85(6):1357-1366. doi: 10.1111/bcp.13907. Epub 2019 Apr 13.

PMID:
30811063
13.

Liquid biopsy and minimal residual disease - latest advances and implications for cure.

Pantel K, Alix-Panabières C.

Nat Rev Clin Oncol. 2019 Jul;16(7):409-424. doi: 10.1038/s41571-019-0187-3. Review.

PMID:
30796368
14.

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.

Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E.

Oncogene. 2019 Feb;38(7):950-964. doi: 10.1038/s41388-018-0579-3. Epub 2018 Nov 26.

PMID:
30478447
15.

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes.

Soler A, Cayrefourcq L, Mazard T, Babayan A, Lamy PJ, Assou S, Assenat E, Pantel K, Alix-Panabières C.

Sci Rep. 2018 Oct 29;8(1):15931. doi: 10.1038/s41598-018-34365-z.

16.

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.

Croset M, Pantano F, Kan CWS, Bonnelye E, Descotes F, Alix-Panabières C, Lecellier CH, Bachelier R, Allioli N, Hong SS, Bartkowiak K, Pantel K, Clézardin P.

Cancer Res. 2018 Sep 15;78(18):5259-5273. doi: 10.1158/0008-5472.CAN-17-3058. Epub 2018 Jul 24.

17.

Chromosomal Aberrations Associated with Sequential Steps of the Metastatic Cascade in Colorectal Cancer Patients.

Joosse SA, Souche FR, Babayan A, Gasch C, Kerkhoven RM, Ramos J, Fabre JM, Riethdorf S, König A, Wikman H, Alix-Panabières C, Pantel K.

Clin Chem. 2018 Oct;64(10):1505-1512. doi: 10.1373/clinchem.2018.289819. Epub 2018 Jul 20.

18.

Abstracts from the 11th International Symposium on Minimal Residual Disease, 3-5 May 2018, Montpellier, France.

Alix-Panabières C, Pantel K.

Clin Exp Metastasis. 2018 Mar;35(3):167-217. doi: 10.1007/s10585-018-9911-0. No abstract available.

PMID:
30008067
19.

11th International Symposium on Minimal Residual Cancer (ISMRC): 3-5 May 2018, Montpellier, France.

Alix-Panabières C, Pantel K.

Clin Exp Metastasis. 2018 Mar;35(3):87-90. doi: 10.1007/s10585-018-9909-7. Epub 2018 Jul 6. No abstract available.

PMID:
29980892
20.

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.

Markou A, Lazaridou M, Paraskevopoulos P, Chen S, Świerczewska M, Budna J, Kuske A, Gorges TM, Joosse SA, Kroneis T, Zabel M, Sedlmayr P, Alix-Panabières C, Pantel K, Lianidou ES.

Clin Chem. 2018 Feb;64(2):297-306. doi: 10.1373/clinchem.2017.275503. Epub 2017 Nov 9.

21.

Detection of Circulating Plasma Cells in Multiple Myeloma.

Alix-Panabières C, Pantel K.

Clin Chem. 2017 Dec;63(12):1797-1798. doi: 10.1373/clinchem.2017.275446. Epub 2017 Sep 18. No abstract available.

22.

Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.

Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, Kotsantis I, Avgeris M, Mazel M, Perisanidis C, Sasaki C, Alix-Panabières C, Lianidou E, Psyrri A.

Ann Oncol. 2017 Aug 1;28(8):1923-1933. doi: 10.1093/annonc/mdx206.

PMID:
28838214
23.

EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.

Soler A, Cayrefourcq L, Mazel M, Alix-Panabières C.

Methods Mol Biol. 2017;1634:263-276. doi: 10.1007/978-1-4939-7144-2_22.

PMID:
28819858
24.

Biological labels: Here comes the spaser.

Alix-Panabières C, Pantel K.

Nat Mater. 2017 Jul 26;16(8):790-791. doi: 10.1038/nmat4943. No abstract available.

PMID:
28748959
25.

Characterization of single circulating tumor cells.

Alix-Panabières C, Pantel K.

FEBS Lett. 2017 Aug;591(15):2241-2250. doi: 10.1002/1873-3468.12662. Epub 2017 May 27. Review.

26.

Tumour microenvironment: informing on minimal residual disease in solid tumours.

Pantel K, Alix-Panabières C.

Nat Rev Clin Oncol. 2017 Jun;14(6):325-326. doi: 10.1038/nrclinonc.2017.53. Epub 2017 Apr 11. Review. No abstract available.

PMID:
28397823
27.

Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer.

Pantel K, Alix-Panabières C.

Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):73-74. doi: 10.1038/nrgastro.2016.198. Epub 2017 Jan 18. Review. No abstract available.

PMID:
28096542
28.

Epithelial-mesenchymal plasticity in circulating tumor cells.

Alix-Panabières C, Mader S, Pantel K.

J Mol Med (Berl). 2017 Feb;95(2):133-142. doi: 10.1007/s00109-016-1500-6. Epub 2016 Dec 24. Review.

PMID:
28013389
29.

Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.

Alix-Panabières C, Cayrefourcq L, Mazard T, Maudelonde T, Assenat E, Assou S.

Clin Chem. 2017 Mar;63(3):700-713. doi: 10.1373/clinchem.2016.263582. Epub 2016 Dec 22.

30.

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.

Kuske A, Gorges TM, Tennstedt P, Tiebel AK, Pompe R, Preißer F, Prues S, Mazel M, Markou A, Lianidou E, Peine S, Alix-Panabières C, Riethdorf S, Beyer B, Schlomm T, Pantel K.

Sci Rep. 2016 Dec 21;6:39736. doi: 10.1038/srep39736.

31.

Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?

Leung F, Kulasingam V, Diamandis EP, Hoon DS, Kinzler K, Pantel K, Alix-Panabières C.

Clin Chem. 2016 Aug;62(8):1054-60. doi: 10.1373/clinchem.2016.260331. Epub 2016 Jun 3. No abstract available.

32.

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.

Alix-Panabières C, Pantel K.

Cancer Discov. 2016 May;6(5):479-91. doi: 10.1158/2159-8290.CD-15-1483. Epub 2016 Mar 11. Review.

33.

Liquid biopsy: Potential and challenges.

Pantel K, Alix-Panabières C.

Mol Oncol. 2016 Mar;10(3):371-3. doi: 10.1016/j.molonc.2016.01.009. Epub 2016 Feb 1. No abstract available.

34.

Functional studies on circulating and disseminated tumor cells in carcinoma patients.

Alix-Panabières C, Bartkowiak K, Pantel K.

Mol Oncol. 2016 Mar;10(3):443-9. doi: 10.1016/j.molonc.2016.01.004. Epub 2016 Jan 18. Review.

35.

Cell lines from circulating tumor cells.

Pantel K, Alix-Panabières C.

Oncoscience. 2015 Aug 20;2(10):815-6. eCollection 2015. No abstract available.

36.

Functional Studies on Viable Circulating Tumor Cells.

Pantel K, Alix-Panabières C.

Clin Chem. 2016 Feb;62(2):328-34. doi: 10.1373/clinchem.2015.242537. Epub 2015 Dec 4. Review.

37.

Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.

Alix-Panabières C, Pantel K.

Expert Rev Mol Diagn. 2015;15(11):1411-7. doi: 10.1586/14737159.2015.1091729. Epub 2015 Sep 21. Review.

PMID:
26390240
38.

Frequent expression of PD-L1 on circulating breast cancer cells.

Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, Rossille D, Maudelonde T, Fest T, Alix-Panabières C.

Mol Oncol. 2015 Nov;9(9):1773-82. doi: 10.1016/j.molonc.2015.05.009. Epub 2015 Jun 9.

39.

Establishment and characterization of a cell line from human circulating colon cancer cells.

Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, Alix-Panabières C.

Cancer Res. 2015 Mar 1;75(5):892-901. doi: 10.1158/0008-5472.CAN-14-2613. Epub 2015 Jan 15.

40.

Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.

Pantel K, Alix-Panabières C.

Bonekey Rep. 2014 Nov 19;3:584. doi: 10.1038/bonekey.2014.79. eCollection 2014. Review.

41.

Challenges in circulating tumour cell research.

Alix-Panabières C, Pantel K.

Nat Rev Cancer. 2014 Sep;14(9):623-31. doi: 10.1038/nrc3820. Epub 2014 Jul 31. Review.

PMID:
25154812
42.

[The circulating tumor cells: liquid biopsy of cancer].

Alix-Panabieres C, Pantel K.

Klin Lab Diagn. 2014 Apr;(4):60-4. Review. Russian.

PMID:
25080805
43.

[Circulating tumor cells: cornerstone of personalized medicine].

Rafii A, Vidal F, Rathat G, Alix-Panabières C.

J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):640-8. doi: 10.1016/j.jgyn.2014.06.009. Epub 2014 Jul 10. Review. French.

44.

[Circulating tumor cells: liquid biopsy].

Alix-Panabières C, Pierga JY.

Bull Cancer. 2014 Jan 1;101(1):17-23. doi: 10.1684/bdc.2014.1883. Review. French.

PMID:
24445939
45.

Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.

Ramirez JM, Fehm T, Orsini M, Cayrefourcq L, Maudelonde T, Pantel K, Alix-Panabières C.

Clin Chem. 2014 Jan;60(1):214-21. doi: 10.1373/clinchem.2013.215079. Epub 2013 Nov 19.

46.

Technologies for detection of circulating tumor cells: facts and vision.

Alix-Panabières C, Pantel K.

Lab Chip. 2014 Jan 7;14(1):57-62. doi: 10.1039/c3lc50644d. Epub 2013 Oct 21. Review.

PMID:
24145967
47.

Real-time liquid biopsy in cancer patients: fact or fiction?

Pantel K, Alix-Panabières C.

Cancer Res. 2013 Nov 1;73(21):6384-8. doi: 10.1158/0008-5472.CAN-13-2030. Epub 2013 Oct 21. Review.

48.

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.

Alix-Panabières C, Pantel K.

Ann Transl Med. 2013 Jul;1(2):18. doi: 10.3978/j.issn.2305-5839.2013.06.02.

49.

Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

Denève E, Riethdorf S, Ramos J, Nocca D, Coffy A, Daurès JP, Maudelonde T, Fabre JM, Pantel K, Alix-Panabières C.

Clin Chem. 2013 Sep;59(9):1384-92. doi: 10.1373/clinchem.2013.202846. Epub 2013 May 21.

50.

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.

Bidard FC, Fehm T, Ignatiadis M, Smerage JB, Alix-Panabières C, Janni W, Messina C, Paoletti C, Müller V, Hayes DF, Piccart M, Pierga JY.

Cancer Metastasis Rev. 2013 Jun;32(1-2):179-88. doi: 10.1007/s10555-012-9398-0. Review.

Supplemental Content

Loading ...
Support Center